Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nuclear Medicine and Biology|April 2, 2019
Design, synthesis and evaluation of <sup>111</sup>In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptorsJohn R Lever, Emily A Fergason-Cantrell, Terry L Carmack, et al.
Journal of Medicinal Chemistry|February 3, 2021
Development of Heterobivalent Theranostic Probes Having High Affinity/Selectivity for the GRPR/PSMARajendra P Bandari, Terry L Carmack, Anil Malhotra, et al.
Molecular Pharmaceutics|April 29, 2024
Albumin-Binding Lutetium-177-Labeled LLP2A Derivatives as Theranostics for MelanomaMichael D Pun, Fabio Gallazzi, Khanh-Van Ho, et al.
Nuclear Medicine and Biology|December 17, 2011
Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogsSusan Z Lever, Rong Xu, Kuo-Hsien Fan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2014
Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418John R Lever, Dennis K Miller, Emily A Fergason-Cantrell, et al.
Nuclear Medicine and Biology|June 13, 2009
Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumorsMelchor V Cantorias, Said D Figueroa, Thomas P Quinn, et al.
Synapse (New York, N.Y.)|December 1, 2015
Cocaine occupancy of sigma1 receptors and dopamine transporters in miceJohn R Lever, Emily A Fergason-Cantrell, Lisa D Watkinson, et al.
Synapse (New York, N.Y.)|October 15, 2013
A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in miceJohn R Lever, Dennis K Miller, Caroline L Green, et al.
Bioconjugate Chemistry|August 15, 2025
Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding <sup>177</sup>Lu-DOTAGA-pIBA-LLP2A Analogues Targeting MelanomaLongbo Li, Aidan Wirrick, Michael D Pun, et al.
Nuclear Medicine and Biology|July 20, 2024
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigenMichael R Lewis, Alexander W Schaedler, Khanh-Van Ho, et al.
Pageof 2